Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Nove Mesto

3 clinical trials in Nove Mesto, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Nove Mesto at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Nove Mesto

Open in trial search

Ischaemic stroke+2

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Atrial fibrillation

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Eli Lilly & Co.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Nove Mesto

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on stroke prevention and atrial fibrillation management are currently underway. Research includes evaluating new oral anticoagulants for preventing blood clots and reducing stroke risk in high-risk patients.

  • Ischemic Stroke Prevention
  • Non-CNS Systemic Embolism
  • Cardioembolic Events

Studies are exploring novel therapeutic approaches using compounds like asundexian and milvexian to improve patient outcomes.

02 Metabolic Disorders

Research initiatives targeting hypertriglyceridemia are examining innovative treatments to manage lipid levels. Studies focus on evaluating plozasiran's effectiveness in reducing triglyceride levels in patients with varying severity.

  • Severe Hypertriglyceridemia
  • Lipid Management
  • Metabolic Health

Clinical investigations aim to establish new therapeutic options for patients with challenging triglyceride disorders.

03 Diabetes and Obesity

Comprehensive studies addressing type 2 diabetes and obesity are exploring new treatment options. Research focuses on comparing oral medications with established treatments like insulin glargine in patients with multiple cardiovascular risk factors.

  • Diabetes Management
  • Weight Management
  • Cardiovascular Risk Reduction

Trials evaluate the effectiveness of orforglipron in patients with complex metabolic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.